Browse our anti-P2RY1 (P2RY1) Antibodies

Mouse (Murine) Purinergic Receptor P2Y, G-Protein Coupled, 1 (P2RY1) interaction partners

1. This study demonstrated that The inhibitory input to mouse cerebellar Purkinje cells is reciprocally modulated by Bergmann glial P2Y1 and AMPA (show GRIA3 Antibodies) receptor signaling.

2. LPS (show TLR4 Antibodies)-induced inflammation levels were comparable in the P2Y1-null and wild-type mice. Specifically, splenomegaly, counts of circulating platelets and white blood cells (lymphocytes and neutrophils), and assessments of lung injury (tissue architecture and cell infiltration) were similar in the P2Y1-null and wild-type mice. I conclude that lung injury during LPS (show TLR4 Antibodies)-induced inflammation in mice is independent of P2Y1 signaling.

3. In P2Y12 (show P2RY12 Antibodies)(-/-) mice, the growth of syngeneic ovarian cancer tumors was reduced by >85% compared with wild-type (WT) mice. In contrast, there was no difference in tumor growth between P2Y1(-/-) and WT mice.

4. In the brain samples, expressions of P2Y4 (show P2RY4 Antibodies) and P2X7 (show P2RX7 Antibodies) were significantly reduced, whereas that of P2Y1 was significantly elevated in an age-dependent manner.

5. Mesenteric endothelial cells are primed by schistosomiasis to a pro-inflammatory phenotype characterized by an increased expression of NTPDases 2 and 3, favoring ADP accumulation and mononuclear cell adhesion, possibly contributing to mesenteric inflammation and schistosomiasis morbidity via P2Y1 receptor signaling.

6. the amounts of AChE activity, AChE catalytic subunit, structure subunit PRiMA and the amount of acetylcholine, in the brain were not, significantly, altered, suggesting the role of P2Y1R in neuron could have different function as that in muscle.

7. In P2Y1R (-/-) mice, the expression of P2Y2 (show P2RY2 Antibodies) receptor in muscle was reduced by over 50 %, as compared to P2Y1R (+/+) mice. P2Y1 receptor regulated the neuromuscular junction gene expression.

8. Our current results suggest that P2Y1 modulates heat responsiveness and chemosensation in muscle afferents to play a key role in the development of pain-related behaviors during ischemia.

9. Provide evidence for purinergic glio-endothelial coupling during neuronal activity, highlighting the role of ATP-mediated activation of eNOS (show NOS3 Antibodies) via P2Y1 receptors in functional hyperemia.

10. P2Y1 couples to and activates TRPV4 (show TRPV4 Antibodies). PKC (show PKC Antibodies) inhibitors prevented P2Y1 receptor activation of TRPV4 (show TRPV4 Antibodies).

Guinea Pig Purinergic Receptor P2Y, G-Protein Coupled, 1 (P2RY1) interaction partners

Human Purinergic Receptor P2Y, G-Protein Coupled, 1 (P2RY1) interaction partners

1. Genomic association study identified deleterious rare variants in P2RY1 in patients with ischemic stroke.

2. Pin1 (show PIN1 Antibodies) induces the ADP-induced migration of human dental pulp cells through P2Y1 stabilization.

3. predominant role of P2Y1 receptors in human embryonic stem cells and a transition of P2Y-IP3R (show ITPR1 Antibodies) coupling in derived cardiovascular progenitor cells are responsible for the differential Ca(2 (show CA2 Antibodies)+) mobilization between these cells.

4. The negative feedback modulation between LncRNA-SARCC/AR complex and HIF-2alpha (show EPAS1 Antibodies) signaling may then lead to differentially modulated RCC (show XRCC1 Antibodies) progression in a VHL (show VHL Antibodies)-dependent manner. Together, these results may provide us a new therapeutic approach via targeting this newly identified signal from LncRNA-SARCC to AR-mediated HIF-2alpha (show EPAS1 Antibodies)/C-MYC (show MYC Antibodies) signals against RCC (show XRCC1 Antibodies) progression.

5. these data highlight a key role of the P2Y1/PI3Kbeta axis in endothelial cell proliferation downstream of ecto (show TRIM33 Antibodies)-F1-ATPase (show DNAH8 Antibodies) activation by apoA-I (show APOA1 Antibodies). Pharmacological targeting of this pathway could represent a promising approach to enhance vascular endothelial protection.

6. ALIX (show PDCD6IP Antibodies) regulates P2Y1 degradation.

7. There is increased expression of P2Y1 receptors in the rectosigmoid mucosa of diarrhea-predominant irritable bowel syndrome patients.

8. High extracellular NaCl induces priming of the NLRP3 (show NLRP3 Antibodies) inflammasome in RPE (show RPE Antibodies) cells, in part via P2Y1 receptor signaling

9. aim of this study was to evaluate the effects of platelet receptor gene (P2Y12 (show P2RY12 Antibodies), P2Y1) and glycoprotein gene (GPIIIa (show ITGB3 Antibodies)) polymorphisms, as well as their interactions, on antiplatelet drug responsiveness and clinical outcomes in patients with acute MIS (show AMH Antibodies)

10. Synergistic inhibition of both P2Y1 and P2Y12 (show P2RY12 Antibodies) adenosine diphosphate receptors by GLS (show GLS Antibodies)-409 immediately attenuates platelet-mediated thrombosis and effectively blocks agonist-stimulated platelet aggregation irrespective of concomitant aspirin therapy.

Cow (Bovine) Purinergic Receptor P2Y, G-Protein Coupled, 1 (P2RY1) interaction partners

1. P2Y1 receptor-mediated responses involve Flt3 (show FLT3 Antibodies) transactivation, and may identify a unique mechanism whereby cancer chemotherapy with receptor tyrosine kinase (show RET Antibodies) inhibitors promotes vascular dysfunction.

2. Purinergic P2Y1 receptor signaling mediates wound stimuli-induced cyclooxygenase-2 (show PTGS2 Antibodies) expression in intestinal subepithelial myofibroblasts.

3. P2Y1 and P2Y13 (show P2RY13 Antibodies) receptors play a major role in vasa (show DDX4 Antibodies) vasorum endothelial cells growth responses.